These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Appropriate prescribing in asthma. PACT data have drawbacks. Campbell M, Bateman DN, Roberts SJ, Smith JM. BMJ; 1995 Apr 22; 310(6986):1069. PubMed ID: 7728078 [No Abstract] [Full Text] [Related]
3. Which patients are prescribed inhaled anti-asthma drugs? Roberts SJ, Bateman DN. Thorax; 1994 Nov 22; 49(11):1090-5. PubMed ID: 7831622 [Abstract] [Full Text] [Related]
5. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. Shelley M, Croft P, Chapman S, Pantin C. BMJ; 1996 Nov 02; 313(7065):1124-6. PubMed ID: 8916701 [Abstract] [Full Text] [Related]
9. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. Bradlow J, Coulter A. BMJ; 1993 Nov 06; 307(6913):1186-9. PubMed ID: 8251847 [Abstract] [Full Text] [Related]
13. How conducting a clinical trial affects physicians' guideline adherence and drug preferences. Andersen M, Kragstrup J, Søndergaard J. JAMA; 2006 Jun 21; 295(23):2759-64. PubMed ID: 16788131 [Abstract] [Full Text] [Related]
15. Impact of an interest in asthma on prescribing costs in general practice. Jones K. Qual Health Care; 1992 Jun 21; 1(2):110-3. PubMed ID: 10136839 [Abstract] [Full Text] [Related]